CARDIO Flashcards

1
Q
A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Non-pharmacological tx of htn

A

-Should be continued even if drug therapy is started-Regular aerobic exercise (can reduce daytime BP by 3.2/2.7 mmHg) -Reduction of alcohol intake -Moderate sodium restriction -Healthy eating -Weight reduction in overweight patients (5 kg weight loss can reduce BP by 7/3 mmHg)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Pharmacological tx of htn

A

-Begin with one drug at a low to moderate dose and review patient regularly
-If not reached within 3 months of treatment then add a low dose of a second drug from a different class -First line drugs;
• ACEI-Captopril (12.5-50mg daily) OR Perindopril arginine (4-8 mg)
• ARB-Candesartan (8-32 mg daily) OR Irbesartan (150-300mg daily)
• Dihydroperidone calcium channel blockers-Amlodipine (5-10mg) OR Nifedipine (20-120mg)
• Thiazide diuretic-Hydrochlorothiazide (12.5-50mg)
-Following combinations are effective;
-a thiazide or thiazide-like diuretic with an ACEI, ARB or beta blocker
-an ACEI or ARB with a calcium channel blocker
-a beta blocker with a dihydropyridine calcium channel blocker
-an ACEI or ARB with a dihydropyridine calcium channel blocker and a thiazide or thiazide-like diuretic.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Mx pathway for HTN

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Complications of HTN

A

LVH/Failure–> due to increased pressure in ventricle
-AF–> due to diastolic dysfunction
-Cerebrovascular ischemic events (stroke)à stroke due to carotid atheroma, SAH due to increased pressure
-Hypertensive encephalopathy–> transient disturbance in speech/vision
-Renal failure–> benign nephrosclerosisàarteriosclerotic changes (in efferent and afferent tubules) causes progressive decrease in GFR and tubular dysfunction (mainly affects afferent wall through thickening via hyaline arteriosclerosis)à causes appearance of grain kidney (due to microangiopathy and microinfarcts causing glomerular scarring in the cortex) and protein/haematuria
-Retinopathy;
•Cotton wool exudates – ischemia, infarction, fade in few weeks
•Hard exudates (cholesterol leakages) and dot hemorrhages (microaneurysms or ruptured microvasculature)
•Generalised thickening of the arterioles
-IHD–>MI
-PVD–>due to hyaline arteriosclerosis and atherosclerosis (HTN causes epithelial dysfunction which promotes atherosclerosis)
-AAA/Dissection due to internal elastic lamina thickening, SM hypertrophy, fibrous tissue deposits and vessel dilation/tortuation causes walls to become less compliant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the symptoms of ARF

A
  • Subcutaneous nodules–> occur on high pressure areas
  • Pancarditis–> often causing cardiomegaly- knees, elbows
  • Polyarthritis
  • Fever
  • Sydenham chorea- due to the attack of the basal ganglia
  • Erythema marginatum- due to the attack of membranes
  • Weak heart sounds (due to inflammation), pericardial friction rub, murmur and cardiac failure
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are the investigations for ARF
-Why aren’t cultures done

A
  • ASO= titre of Ab against strep lysin O (highly specific for strep)
  • Anti DNAase B= Ab titres against strep
  • Antistreptokinase= Ab against streptokinase
  • Antihyaluronidase= strep produces hyaluronidase (Ab mean past infection)
  • ECG= prolonged PR interval
  • CRP= elevated
  • ESR= elevated
  • CXR= LV hypertrophy (in RHD)
  • Echo= valve vegetations/stenosis
  • -> no culture as the strep infection will have cleared and it will be an autoimmune response causing damage
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the management for ARF/RHD

A
  • Penicillin prophylaxis for patients who have had acute rheumatic fever–> in order to prevent recurrent attacks of ARF leading to RHD
  • Medical management for patients with minor valve disease (eg. anticoagulation, ventricular rate control, diuretics, etc.)
  • Valve replacement, balloon valvuloplasty for patients with severe valve disease
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the aetiology of IE

A
  • *-bad oral hygiene-**oral streptococci or staph aureus- form a plaque layer/biofilm- able to do this due to production of dextrose that aids in adherenceà if pt has dental problems can move into blood stream and travel to heart
  • IV drug user-staph aureus, oral strep or gram neg bacteria- cause right sided endocarditis (tricuspid valve)-organisms that have come from the skin or dirty needles
  • *-prosthetic valves-** if less than 2 months most likely hospital acquired- coag negative staph
  • *-prosthetic valves-** if greater than 2 months most likely environmental causeà
  • damaged valves- RHD/high pressure areas (mitral regurg, aortic regurg
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are the examination findings of IE

A

General signs: weight loss; pallor (anaemia), fever (low grade and persistant in SBE, severe in ABE)

  • *Hands:** splinter haemorrhages; clubbing (within six weeks of onset); Osler’s nodes (rare-painful erythematous nodules); Janeway lesions (very rare), petichae and purpura
  • *Mouth:** mucosal petechiae
  • *Arms:** evidence of intravenous drug use
  • *Eyes:** pale conjunctivae (anaemia); retinal or conjunctival haemorrhages—Roth’s spots
  • *Heart:** signs of underlying heart disease:

(1) acquired (mitral regurgitation, mitral stenosis, aortic stenosis, aortic regurgitation);
(2) congenital (patent ductus arteriosus, ventricular septal defect, coarctation of the

aorta) ;
(3) prosthetic valves.

Abdomen: splenomegaly.

Peripheral evidence of embolisation to limbs or central nervous system.

Urinalysis: haematuria (a fresh urine specimen will then show dysmorphic red cells and red cell

casts on microscopy).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What investigations would you do for IE

A
  • Blood test- blood culture, FBC, ESR, CRP
  • Echocardiogram- detect vegetations and abscesses and look at valvular damage
  • CXR- look at cardiomegaly
  • ECG- look for infarct or arrhythmia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

How is IE managed/treated

A

-Antibiotics

Empirical therapy;
-gentamicin IV, once daily;
PLUS

-benzylpenicillin 1.8 g (child: 50 mg/kg up to 1.8 g) IV, 4-hourly

PLUS

-flucloxacillin 2 g (child: 50 mg/kg up to 2 g) IV, 4-hourly.

In those with a history of IVDU or fulminant endocarditis substitute benzylpenicillin with vancomycin

  • Restoration of damaged valve
  • Resolution of preceding factor (ie. Fix immunosuppression)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the Jones Criteria- is it used in Aus

A
  • Due to its reduced sensitivity in a high incidence population, only the modified Jones criteria is used in diagnosis of ARF
  • It has criteria for low and high risk populations and initial vs recurrent attacks
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

How is IE diagnosed- what is the criteria

A
  • Diagnosed with Dukes criteria
  • Need 2 major clinical criteria or 1 major and 3 minor
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

How does oedema form
-causes of pedal and pulmonary oedema

A
  • Occurs when excess fluid moves into the tissues for multiple reasons such as; increased ECF (due to CHF, renal failure), high venous pressure (DVT), hypoalbuminaemia (causing loss of oncotic capillary pressureà due to liver failure/nephrotic syndrome), increased cap permeability (infection/inflamm, sepsis)
  • Pedal oedema: is oedema occurring in the feet/lower limbs- due to insufficiency of leg venules or CHF causing fluid backflow into the peripheries
  • *-Pulmonary oedema:** fluid in the lungs most often caused by CHF in which there is increased pressure in the heart causing backflow into pulm artery or LV heart failure
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What portion of the heart does the LAD supply

A

Supplies anterior left ventricle, anterior septum and apex circumferentially= Anterior Infarct

20
Q

What portion of the heart does the RCA supply

A

Supplies posterior left ventricle, posterior septum and right ventricle wall= Inferior Infarct

21
Q

What part of the heart does the LCA supply

A

Supplies lateral left ventricle except the apex = Lateral Infarct

22
Q

What medications are used in the treatment of angina

A

Nitrates= cause vasodilation and lower the preload and afterload, decreasing myocardial 02 requirements (short acting)
Beta blockers= decrease myocardial o2 demand by reducing HR, BP and contractility
Ca-Channel antagonist= inhibit inflow of Ca into vascular SMC causing vasodilation and reduced contractility
K channel activator= longer acting vasodilator

23
Q

What is the management for an acute MI

A

-M= morphine; pain relief- relieves adrenergic stimulation- 5-10mg
-O= oxygen
-N= nitrates
Sublingual GTN – first aid measure in UA or threatened infarction
IV Nitrates – to treat LV failure or persistent cardiac pain
IV B-Blockers – reduce arrhythmias and reduce workload on heart, do NOT use if in HF/bradycardia
Calcium channel antagonists – alternative to B-blocker
Statin- aids in plaque stabalisation
-Don’t use aspirin in RV damage- GTN is used to decrease venous pooling so decrease workload on heart- if pt has RV damage the pooling of blood in the right side aids in increase pre-load and increasing CO
-A= aspirin + ticagrelor= anticoagulants to reduce the risk of thromboembolism and prevent re-infarction(300mg PO)
-Reperfusion= using thrombolysis (tissue plasminogen activase (TPA)) to remove the clot, or percutaneous coronary intervention (PCI)(placing a stent) à within 1h

24
Q

What are some acute complications of an MI

A
  • Cardiac dysfunction
  • Arrhythmias- due to scarring causing abnormalities in conduction pathways or inflamm mediators causing abnormal excitation
  • Extension of infarction
  • Pulmonary oedema- due to backflow from LA
  • Cardiogenic shock- decreased CO due to heart being unable to effectively pump
  • Fibrous pericarditis- full thickness infarction leads to fibrin being deposited
  • Mural thrombis/Emboli due to stasis of blood and endocardial damage causing a thrombogenic surface
  • Myocardial wall rupture- due to active lysis of tissues by macrophages
  • Tamponade- due to myocardial wall ruptureà causes SCD due to blood collecting in pericardium and stopping heart from pumping
  • Papillary muscle rupture- causing mitral regurg
  • Rupture ventricular septum
25
Q

What are some chronic complications of an MI

A
  • Ventricular aneurysm- ventricular wall dilates under the pressure of the blood (wall is already weak)
  • Congestive heart failure
  • Thinning and mural thrombosis
  • Papillary muscle contraction- leading to mitral regurg
26
Q

What investigations are useful in diagnosing heart failure

A
  • identify and assess precipitating factors and treatable causes of CHF
  • Blood work: CBC, electrolytes (including calcium and magnesium), BUN, creatinine, fasting blood glucose, HbA1c, lipid profile, liver function tests, serum TSH ± ferritin, BNP, uric acid
  • ECG: look for chamber enlargement, arrhythmia, ischemia/infarction
  • CXR: cardiomegaly, pleural effusion, redistribution, Kerley B lines, bronchiolar-alveolar cuffing, batwing appearance
  • Echo: systolic function (LVEF),
27
Q

What is the management for CHF

A
  • Acute heart failure is a medical emergency
  • Chronic heart failure:
  • Advise to; Stop smoking, Eat less salt, Optimize weight & nutrition.
  • Treat the cause (eg if dysrhythmias; valve disease).
  • Treat exacerbating factors (anaemia, thyroid disease, infection, BP).
  • Avoid exacerbating factors, eg NSAIDS (fluid retention) and verapamil (–ve inotrope).

Fluid management

Daily fluid charts and use of fluid management plan

Limiting fluid to 1.5L fluid per day

-Sodium restriction advice

  • Regular assessment for depression
  • Obesity management and advice

-Drugs

ACE inhibitors
-Captopril (6.25 mg daily) OR enalapril (2.5 mg daily) OR perindopril arginine (2.5mg daily)

ARB
-Irbesartan(75mg daily) OR telmisartan (40mg daily)

Beta blocker
-Bisoprolol (1.25mg daily) or metoprolol succinate modified-release (23.75 mg daily)

Aldosterone antagonist
-Eplerenone (25mg daily) OR spironolactone (25mg daily)

Angiotensin-receptor neprilysin inhibitor

Diuretics
-Frusemide (20-40mg daily)

Digoxin
-added in addition when symptoms are not adequately controlled

-Therapy for advanced stage heart failure

Pleurocentesis and pericardiocentesis aspiration

28
Q

What is the stanford criteria- what does it classify -which requires surgical intervention

A

Stanford criteria classifies dissections into type A and B -Type A= affects ascending aorta and arch and requires surgical management Type B= affects the vessel beyond the brachiocephalic vessels and can be controlled with BP medication

29
Q

What is the debakey criteria- what does it classify

A

Debakey classifies disections into affecting; 1. the entire aorta 2. the ascending aorta 3. the descending aorta

30
Q

What investigations can diagnose a DVT

A
  • Venous duplex ultrasound (Doppler)- able to examine blood vessels and blood flow- determine if there are visible clots
  • INR-international normalised ratio- determines clotting time and is used to determine the effects of oral anticoagulant
  • Activated partial thromboplastin time- functional measure of the intrinsic and common pathway
  • Wells score
  • Quantiative D-Dimer level assays of the coagulation cascadeà determines how long it takes to clot when reagents are added to plasma
  • Don’t do D-dimer if not sure that it will be a DVT- only do it if there are multiple risk factors
31
Q

How is DVT managed

A
  • Before starting anticoagulant therapy; collect blood to measure the patient’s activated partial thromboplastin time (APTT), international normalised ratio (INR), full blood count, kidney function, liver biochemistry, as well as a beta human chorionic gonadotrophin (hCG) test for women of childbearing age.
  • Analgesia
  • Elevation
  • Oral factor Xa inhibitors (eg apixaban, rivaroxaban) are preferred to dabigatran or warfarin to treat proximal DVT and PE because they do not require parenteral anticoagulation for initiation–> don’t use NOAC in renally impaired
  • Apixaban–> 10mg orally for 7 days
  • Rivaroxaban–> 15mg orally for 21 days

Renally impaired patients
-Warfarin parenterally initially then oral

DVT in pregnancy/cancer
-Enoxaparin

  • For patients where the DVT/PE was initiated by a stimuli no longer present–> continue anticoag tx for 3 months
  • Heparin is reversed with protamine sulphateà inhibits formation and action of thromboplastin
  • Can reverse warfarin by giving VitK, or give fresh frozen plasma (with clotting factors) for immediate reversal
  • Recurrent DVT’s require permanent anti-coagulants to prevent clot formation
32
Q

What is Wells Score

A

The Wells’ Criteria risk stratifies patients for a pulmonary embolism (PE) and provides an estimated pre-test probability of PE

  • Above 6 indicates high probability of PE
  • Between 2 and 6 indicates moderate probability
  • Below 2 is low probability
  • suggests diagnosis of PE
33
Q

In an acute massive PE;

  • What ECG changes may be present
  • What ABG changes may be present
  • What CXR changes may be present
A

ECG; sinus tachycardia, RBBB, AF, PVCS, S1 Q3 T3 (S wave in lead I, a Q wave in lead III, and an inverted T wave in lead III- appears in larger emboli)
ABG; reduced Pa02, acidotic
CXR; usually normal
Features; severe cyanosis, loud P2, elevated JVP, RV gallop, hypotension (systolic below 90), pulselessness or profound bradycardia (below 40)

34
Q

In an acute small PE

  • What ECG changes may be present
  • What ABG changes may be present
  • What CXR changes may be present
A

ECG; sinus tachy
ABG; may be normal or reduced Pa02
CXR; pleural effusion, raised hemidiaphragm, opacities
Features; pleural rub, crackles on auscultation, low grade fever (dead tissue releasing cytokines)

35
Q

What investigations can diagnose a PE

A
  • FBC (low platelet), U&E, baseline clotting, ABG
  • D-dimer’ is a fibrin degradation product present in the blood after a blood clot is degraded by fibrinolysis-> only perform if patient has risk factors
  • CXR; may be normal or will show hypovolemia, dilated pulmonary artery (on affected side), small pleural effusion, wedge shaped opacities (dead tissue)
  • VQ scan; able to see if parts of the lungs are being ventilated but not perfused
  • CT pulm angiogram; able to see blockage
  • ECG; sinus tachy, afib, RBBB, RAD, S1Q3T3